Coagulation abnormalities in patients with chronic liver disease in Pakistan.

OBJECTIVE To determine the coagulation abnormalities and relationship between abnormal clotting tests and the risk of gastrointestinal bleeding (GI) among chronic liver disease (CLD) patients admitted at a tertiary care hospital in Pakistan. METHODS Adult CLD patients admitted at Liaquat University Hospital Jamshoro, during Nov 2004-Oct 2005, were included in the study. The patients blood were tested for coagulation abnormalities including prothrombin time (PT), activated partial thromboplastin time (aPTT), platelet count and plasma fibrinogen. Association was seen between the abnormal clotting tests and the gastrointestinal bleeding by calculating relative risk (RR) with 95% confidence interval. RESULTS PT was prolonged in 88% and aPTT was raised in 71% cases of CLD. Both PT and aPTT were prolonged in 67% CLD cases. Approximately 37% CLD cases had decreased platelet count and 15% cases had decreased serum fibrinogen level. Relative risk of GI bleeding with abnormal clotting tests in CLD cases were weakly positive for PT (RR = 1.02; 95% CI, 0.49-2.10), negative for aPTT (RR = 0.83; 95% CI, 0.47-1.45), strongly positive for decreased platelet counts (RR = 1.96; 95% CI, 1.08-3.56) and also for decreased fibrinogen level (RR = 1.47; 95% CI, 0.64-3.35). CONCLUSION Coagulation abnormalities were profound in CLD. Decrease platelet counts and fibrinogen levels were related with GI bleeding but PT and aPTT were not significantly related with GI bleeding in patients with chronic liver disease. Nevertheless, these parameters (PT and aPTT) were still used as prognostic markers.

[1]  A. Tripodi.  Tests of coagulation in liver disease. , 2009, Clinics in liver disease.

[2]  H. Niessner,et al.  Coagulation Abnormalities in Liver Disease , 2008, Seminars in thrombosis and hemostasis.

[3]  J. Thachil.  Relevance of clotting tests in liver disease , 2008, Postgraduate Medical Journal.

[4]  V. Drug,et al.  [Hemostatic disorders in liver disease]. , 2008, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[5]  M. Peck‐Radosavljevic.  Review article: coagulation disorders in chronic liver disease , 2007, Alimentary pharmacology & therapeutics.

[6]  P. D. de Groot,et al.  Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.

[7]  J. Reverter,et al.  Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes , 2006, Journal of thrombosis and haemostasis : JTH.

[8]  P. Mannucci,et al.  Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No , 2006, Journal of thrombosis and haemostasis : JTH.

[9]  S. Lecleire,et al.  Acute Upper Gastrointestinal Bleeding in Patients With Liver Cirrhosis and in Noncirrhotic Patients: Epidemiology and Predictive Factors of Mortality in a Prospective Multicenter Population-Based Study , 2005, Journal of clinical gastroenterology.

[10]  J. Bosch,et al.  The relevance of portal pressure and other risk factors in acute gastro‐oesophageal variceal bleeding , 2004, Alimentary pharmacology & therapeutics.

[11]  S. Ragot,et al.  Cirrhosis and bleeding: the need for very early management. , 2003, Journal of hepatology.

[12]  T. Hussain,et al.  Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. , 2003, JPMA. The Journal of the Pakistan Medical Association.

[13]  V. Brancaccio,et al.  Coagulation disorders in liver disease. , 2002, Seminars in liver disease.

[14]  L. Forman,et al.  Predicting the prognosis of chronic liver disease: An evolution from child to MELD , 2001, Hepatology.

[15]  A. Magnano,et al.  Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? , 2001, Hepatology.

[16]  K. Mullen,et al.  Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease , 2000, American Journal of Gastroenterology.

[17]  J. Llach,et al.  Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension , 2000, Hepatology.

[18]  A. Zaman,et al.  Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease , 1999, American Journal of Gastroenterology.

[19]  C. Sabin,et al.  Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding , 1999, Gut.

[20]  H. Polk,et al.  Clarification of Risk Factors for Abdominal Operations in Patients with Hepatic Cirrhosis , 1984, Annals of surgery.

[21]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.